Literature DB >> 7992746

MR measurements of the hippocampus for lateralization of temporal lobe epilepsy: value of measurements of the body vs the whole structure.

J H Kim1, R D Tien, G J Felsberg, A K Osumi, N Lee.   

Abstract

OBJECTIVE: Measurements of the volume of the hippocampus have been used preoperatively to determine the side of the hippocampus involved in patients with intractable temporal lobe epilepsy. However, the method used is time consuming and requires special training. The purpose of this study was to determine the validity of using measurements of the volume of the hippocampal body as a substitute for measurements of the volume of the whole hippocampus in patients with temporal lobe epilepsy. SUBJECTS AND METHODS: The study group consisted of 33 patients with intractable temporal lobe epilepsy due to presumed hippocampal sclerosis and 30 control subjects. Of the 33 patients with intractable temporal lobe epilepsy, 30 had hippocampal sclerosis and three had normal findings on pathologic examination of the hippocampus. T2-weighted fast spin-echo images were used to determine hippocampal volumes. Volumes were calculated by summing the sectional areas of the entire hippocampus and of the hippocampal body. Correlation between the volume of the hippocampal body and the volume of the whole hippocampus was determined. The sensitivity and specificity of measurement of the volume of the hippocampal body for lateralizing the foci responsible for seizures in patients with presumed hippocampal sclerosis were compared with those of measurement of the volume of the whole hippocampus.
RESULTS: Significant linear relationships were noted between volumes of the hippocampal body and volumes of the whole hippocampus (p < .001). The sensitivity and specificity of measurements of volumes of the hippocampal body were identical to those of measurements of volumes of the whole hippocampus (87% and 100%, respectively).
CONCLUSIONS: Our results show that segmental MR measurements of the body of the hippocampus are as accurate as measurements of the whole hippocampus for lateralizing temporal lobe epilepsy before surgery. Because segmental measurements are less time consuming and require less experience to perform, they are considered the procedure of choice.

Entities:  

Mesh:

Year:  1994        PMID: 7992746     DOI: 10.2214/ajr.163.6.7992746

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  5 in total

1.  Bilateral hippocampal volume increases after long-term lithium treatment in patients with bipolar disorder: a longitudinal MRI study.

Authors:  Kaan Yucel; Margaret C McKinnon; Valerie H Taylor; Kathryn Macdonald; Martin Alda; L Trevor Young; Glenda M MacQueen
Journal:  Psychopharmacology (Berl)       Date:  2007-08-20       Impact factor: 4.530

2.  Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report.

Authors:  J D Bremner; P Randall; E Vermetten; L Staib; R A Bronen; C Mazure; S Capelli; G McCarthy; R B Innis; D S Charney
Journal:  Biol Psychiatry       Date:  1997-01-01       Impact factor: 13.382

3.  An assessment of MEG coherence imaging in the study of temporal lobe epilepsy.

Authors:  Kost Elisevich; Neetu Shukla; John E Moran; Brien Smith; Lonni Schultz; Karen Mason; Gregory L Barkley; Norman Tepley; Valentina Gumenyuk; Susan M Bowyer
Journal:  Epilepsia       Date:  2011-03-02       Impact factor: 5.864

4.  FLAIR signal and texture analysis for lateralizing mesial temporal lobe epilepsy.

Authors:  Kourosh Jafari-Khouzani; Kost Elisevich; Suresh Patel; Brien Smith; Hamid Soltanian-Zadeh
Journal:  Neuroimage       Date:  2009-09-08       Impact factor: 6.556

5.  Correlation of Electroencephalography and Magnetic Resonance Imaging in Patients with Mesial Temporal Sclerosis.

Authors:  Duygu Özkan; Yılmaz Çetinkaya; Ayşegül Özyilmaz; Havva Tuğba Çelik; Cemile Handan Misirli; Hülya Tireli
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.